FEED the BULL

Welcome to Feed the Bull - A home for investment information and interaction.

Tag: maytansinoid

Sort
E.g., 2013-06-20
E.g., 2013-06-20
Enter a comma separated list of user names.

ImmunoGen (IMGN) reported that Bayer HealthCare Pharmaceuticals’ submission of an Investigational New Drug (IND) application for the TAP compound, BAY 94-9343, triggers a $2 million milestone payment to IMGN.

ADVERTISE WITH US